Dimensional Fund Advisors
KPTI icon

Dimensional Fund Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Dimensional Fund Advisors’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,571
Closed -$174K – 3501
2022
Q1 		$174K Hold
1,571
– – ﹤0.01% 3329
2021
Q4 		$152K Hold
1,571
– – ﹤0.01% 3382
2021
Q3 		$137K Sell
1,571
-35
-2% -$3.63K ﹤0.01% 3393
2021
Q2 		$249K Sell
1,606
-8,168
-84% -$1.19M ﹤0.01% 3295
2021
Q1 		$1.54M Hold
9,774
– – ﹤0.01% 2911
2020
Q4 		$2.27M Sell
9,774
-36,733
-79% -$8.51M ﹤0.01% 2777
2020
Q3 		$10.2M Sell
46,507
-5,550
-11% -$1.36M ﹤0.01% 2181
2020
Q2 		$14.8M Sell
52,057
-20,550
-28% -$6.08M 0.01% 2029
2020
Q1 		$20.9M Sell
72,607
-6,009
-8% -$1.66M 0.01% 1716
2019
Q4 		$22.6M Sell
78,616
-2,068
-3% -$449K 0.01% 1969
2019
Q3 		$11.6M Buy
80,684
+7,027
+10% +$953K ﹤0.01% 2287
2019
Q2 		$6.62M Sell
73,657
-1,674
-2% -$134K ﹤0.01% 2560
2019
Q1 		$6.6M Buy
75,331
+30,413
+68% +$3.37M ﹤0.01% 2560
2018
Q4 		$6.31M Buy
44,918
+27,560
+159% +$4.65M ﹤0.01% 2529
2018
Q3 		$4.43M Sell
17,358
-3,199
-16% -$884K ﹤0.01% 2713
2018
Q2 		$5.24M Sell
20,557
-333
-2% -$82.4K ﹤0.01% 2644
2018
Q1 		$4.21M Sell
20,890
-169
-0.8% -$33.7K ﹤0.01% 2686
2017
Q4 		$3.03M Sell
21,059
-210
-1% -$33.7K ﹤0.01% 2770
2017
Q3 		$3.5M Sell
21,269
-309
-1% -$44.3K ﹤0.01% 2703
2017
Q2 		$2.93M Buy
21,578
+3,180
+17% +$471K ﹤0.01% 2756
2017
Q1 		$3.54M Buy
18,398
+994
+6% +$160K ﹤0.01% 2680
2016
Q4 		$2.45M Buy
17,404
+13,515
+348% +$1.83M ﹤0.01% 2768
2016
Q3 		$568K Buy
+3,889
New +$467K ﹤0.01% 3045

Other funds holding KPTI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dimensional Fund Advisors's KPTI Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Karyopharm Therapeutics (KPTI) in Q2 2022, closing a stake of 1,571 shares — an estimated $174K sold.

Dimensional Fund Advisors first reported a position in KPTI in Q3 2016 and held it in 23 quarters. The position peaked at $22.6M in Q4 2019. 149 funds tracked by Wall St. Rank hold KPTI as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Karyopharm Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,571 Karyopharm Therapeutics shares in Q2 2022, an estimated $174K.
  • Dimensional Fund Advisors first reported a position in Karyopharm Therapeutics in Q3 2016 and held it in 23 quarters.
  • Dimensional Fund Advisors's Karyopharm Therapeutics position peaked at $22.6M in Q4 2019.
  • 149 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.